Introduction
There are symptoms, as is the case of choroidal neovascularization (CNV), capable of triggering an acute deterioration of visual acuity (VA) in the context of a previous toxoplasmic retinochoroiditis and very similar in appearance to this disease that make differential diagnosis more difficult. Four patients with chorioretinal lesions resulting in a deterioration of VA are described herein. In these cases, the therapeutic decision was based on a protocol that included different criteria (clinical, immunological and microbiological). The use of this protocol allowed for resolution of symptoms in all cases.
Clinical case
Four patients, all of them female, with ages ranging from 19 to 44 years (mean age: 30 years), came to our inflammation unit reporting sudden loss of VA. They all had a documented history of previous toxoplasmic retinochoroiditis, although only two of them (patients 1 and 2) had received antitoxoplasma treatment. In all patients the presence of macular retinal scars and evidence of activity around the lesion area were observed. Symptoms in all four cases were brought under control and no relapses were observed later on after at least a sixmonth follow-up.
Discussion
Even though in most cases the diagnosis of toxoplasmic retinochoroiditis is based on clinical findings, on certain occasions these do not suffice to establish diagnosis 1 . As illustrated in the images ( fig. 1A and fig. 2B could result in irreversible anatomical and functional sequelae.
On the other hand, as illustrated in patient 3 ( fig. 3A) , the clinical debut of toxoplasmic retinochoroiditis can be very similar to that of CNV (which, on the other hand, is a relatively common sequela and is therefore expected in these patients) and only a few small details observed during exploration (see vasculitis adjacent to the lesion area in fig. 3B ), combined with other findings during screening, can point to the real origin of the lesion. The characteristic image of the relapse in the OCT (hyperreflectivity of the internal retinal layers due to retinal thickening/edema and posterior shadow) sets it a priori clearly apart from that of CNV (hyperreflectivity of the external retinal layers due to neovascular complex and subretinal liquid), although in patient 3 this difference was difficult to assess.
In spite of previous studies that demonstrated the efficacy of photodynamic therapy, the therapeutic approach to choroidal neovessels associated with toxoplasmosis seems to be limited to the use of intravitreal anti-VEFGs. In our case (patients 1 and 4), bevacizumab was prescribed in 3-injection patterns (1.25 mg/0.1 ml) during a four-month period with full resolution of symptoms.
Due to the high prevalence of seroconversion, Toxoplasma gondii IgG positivity has little diagnostic value. Thus, in the case of toxoplasmosis, and specially during the initial stages (less than one week of evolution), based on the patocronia of the inflammatory process, we advocate the use of GW coefficient versus the polymerase chain reaction (PCR) for the detection of toxoplasma (in those probable cases where both tests cannot be performed, which would be the ideal scenario, due to scarce aqueous humor samples): retinal cysts formed after primo-infection contain bradyzoites turning into tachyzoites (the pathogenic form of toxoplasma) which are released when the cyst ruptures (relapse) as a response to stimuli that have not been completely defined yet. 2 However, release takes place at an extremely low pace and these can be observed at late stages, when inflammatory phenomena have already become evident, so that PCR sensitivity at this stage is considerably lower than GW's. 3 In patients with immunodeficiencies (i.e. AIDS) we recommend nevertheless performing a PCR, as their ability to produce antibodies could be compromised. 4 Finally, other diseases whose clinical features resemble those of toxoplasmic retinochoroiditis should be taken into consideration. 5 Thus, and particularly in dubious cases as the ones described herein, we recommend performing thorough studies in order to discard them and increase at the same time the chances for diagnostic and therapeutic success.
